Causes of weight gain Many factors can contribute to obesity
However, because GLP-1 medications slow stomach emptying, some post-cholecystectomy patients experience changes in stool consistency or meal tolerance during the first few weeks
Expansion in obesity management, oral GLP-1 formulations, emerging market penetration, next-generation dual-agonists, and digital health integration offer significant growth opportunities
[PMC free article: PMC209464] [PubMed: 11748259] 273
A fully human monoclonal antibody, Cosentyx, which works by targeting and inhibiting the IL-17A cytokine, thereby suppressing the inflammatory pathway, was previously only authorized as a subcutaneous treatment in these indications
PTS-1 has a strong affinity for small peptides containing N-terminal tyrosine (4-5 amino acids)